REGULATED PRESS RELEASE published on 05/02/2024 at 17:47, 2 years 6 months ago AXA announces an agreement to terminate the sale of a closed life and pensions portfolio at AXA Germany, and that AXA Life Europe has entered into a reinsurance agreement for an in-force Savings portfolio AXA terminates sale agreement for closed life and pensions portfolio, enters reinsurance deal for Savings portfolio. Impact on financial targets and Solvency II ratio AXA Financial Targets Sale Agreement Reinsurance Deal Solvency II Ratio
REGULATED PRESS RELEASE published on 05/02/2024 at 17:45, 2 years 6 months ago AXA: Indicateurs d'activité du T1 2024
REGULATED PRESS RELEASE published on 05/02/2024 at 17:45, 2 years 6 months ago AXA: 1Q24 Activity Indicators
BRIEF published on 04/12/2024 at 18:25, 2 years 6 months ago AXA Announces Details on Voting Rights and Share Capital as of March 2024 Share Capital Voting Rights French Commercial Code Financial Markets Authority AXA
BRIEF published on 04/12/2024 at 18:25, 2 years 6 months ago AXA annonce son nombre total de droits de vote et d'actions au 31 mars 2024 Droits De Vote Capital Social AXA Règlementations Financières Marché Euronext Paris
REGULATED PRESS RELEASE published on 04/12/2024 at 18:20, 2 years 6 months ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2024 AXA, a French public company, reports number of shares and voting rights. Bylaws dictate disclosure of threshold crosses per Article 7 Voting Rights Shares AXA Bylaws French Public Company
REGULATED PRESS RELEASE published on 04/12/2024 at 18:20, 2 years 6 months ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2024 AXA communique le nombre total d'actions et de droits de vote, conformément à la réglementation en vigueur Droits De Vote Actions AXA Réglementation Communication
BRIEF published on 04/12/2024 at 18:05, 2 years 6 months ago AXA met à jour le nombre de ses droits de vote et actions au 31 mars 2024 Droits De Vote Franchissement De Seuil Capital Social AXA Marché Financiers
BRIEF published on 04/12/2024 at 18:05, 2 years 6 months ago AXA updates the number of its voting rights and shares as of March 31, 2024 Share Capital Voting Rights AXA Financial Markets Crossing Threshold
REGULATED PRESS RELEASE published on 04/12/2024 at 18:00, 2 years 6 months ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2024 AXA communique le nombre total d'actions et de droits de vote au 31 mars 2024 conformément à la réglementation financière en vigueur Droits De Vote Réglementation Financière Capital Social AXA Déclaration De Seuil
Published on 11/06/2026 at 22:15, 2 days 9 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 18 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 18 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 18 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 07:10, 11 minutes ago Hypoport delivers solid gross profit growth and an increase in EBIT in the first nine months of 2026
Published on 11/09/2026 at 07:00, 21 minutes ago Sandoz launches new semaglutide treatment option in Brazil, expanding patient access to GLP-1 medicine in key global market
Published on 11/09/2026 at 07:00, 21 minutes ago Cicor receives awards for two major defence programmes
Published on 11/09/2026 at 01:55, 5 hours 26 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 19 hours 10 minutes ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/09/2026 at 07:00, 21 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 21 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 21 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 21 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 12 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026